Scholarly Article Proves Toxic to Gene-Therapy Stocks – Barron’s
Barron’s |
Scholarly Article Proves Toxic to Gene–Therapy Stocks
Barron’s Shares of AveXis and Solid Biosciences have been depressed in morning trading after the publication of an article in the medical journal Human Gene Therapy about severe toxicity in two animal species from administration of a gene therapy similar to one … Gene therapy stocks slammed after scientist reveals safety concerns Gene Therapy May Not Be a Viable Option for Many Patients Gene therapy pioneer James Wilson sounds an alarm on high-dose AAV studies following toxic reactions in monkeys |
